Anders Bjartell

Active 1993–2025

166
Papers
18,664
Citations
84
h-index
149
i10-index

Citations

Citations per year for Anders Bjartell1976: 2 citations1985: 1 citations1990: 1 citations1994: 1 citations1995: 5 citations1996: 2 citations1997: 8 citations1998: 6 citations1999: 9 citations2000: 19 citations2001: 12 citations2002: 18 citations2003: 27 citations2004: 30 citations2005: 22 citations2006: 29 citations2007: 26 citations2008: 38 citations2009: 38 citations2010: 61 citations2011: 98 citations2012: 144 citations2013: 171 citations2014: 146 citations2015: 149 citations2016: 150 citations2017: 121 citations2018: 129 citations2019: 484 citations2020: 563 citations2021: 648 citations2022: 497 citations2023: 450 citations2024: 789 citations2025: 394 citations2026: 30 citations1977–1984: no citations, so these years are not shown1986–1989: no citations, so these years are not shown1991–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,836 citing papers, 20.4% of this breakdownChina: 748 citing papers, 8.3% of this breakdownUnited Kingdom: 630 citing papers, 7% of this breakdownGermany: 535 citing papers, 6% of this breakdownItaly: 498 citing papers, 5.5% of this breakdownCanada: 406 citing papers, 4.5% of this breakdownFrance: 353 citing papers, 3.9% of this breakdownNetherlands: 339 citing papers, 3.8% of this breakdownSweden: 327 citing papers, 3.6% of this breakdownAustralia: 307 citing papers, 3.4% of this breakdownJapan: 264 citing papers, 2.9% of this breakdownSpain: 238 citing papers, 2.7% of this breakdown
0%20.4%Other 28%

Fields

  • Medicine67.5%
  • Biochemistry, Genetics and Molecular Biology21%
  • Immunology and Microbiology3.9%
  • Computer Science2.1%
  • Engineering2.1%
  • Chemistry0.8%
  • Other2.6%

Topics

  • Prostate Cancer Treatment and Research15.9%
  • Prostate Cancer Diagnosis and Treatment12.9%
  • Radiopharmaceutical Chemistry and Applications2.8%
  • Cancer, Lipids, and Metabolism2.6%
  • MicroRNA in disease regulation2%
  • Cancer-related molecular mechanisms research1.7%
  • Other62.1%

Coauthors

All papers

Open in search
  1. Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2019 cited by 1,513

  2. Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 cited by 508

  3. Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bram van Ginneken, Constant R. Noordman, Ivan Slootweg, Christian Roest, Stefan J. Fransen, Mohammed R.S. Sunoqrot, Tone F. Bathen, Dennis Rouw, Jos Immerzeel, Jeroen Geerdink, Chris van Run, Miriam Groeneveld, James Meakin, Ahmet Karagöz, Alexandre Bône, Alexandre Routier, Arnaud Marcoux, Clément Abi-Nader, Cynthia Xinran Li, Dagan Feng, Deniz Alis, Ercan Karaarslan, Euijoon Ahn, François Nicolas, Geoffrey A. Sonn, Indrani Bhattacharya, Jinman Kim, Jun Shi, Hassan Jahanandish, Hong An, Hongyu Kan, Ilkay Oksuz, Liang Qiao, Marc-Michel Rohé, Mert Yergin, Mohamed Khadra, Mustafa E. Şeker, Mustafa S. Kartal, Noëlie Debs, Richard E. Fan, Sara Saunders, Simon J.C. Soerensen, Stefania Moroianu, Sulaiman Vesal, Yuan Yuan, Afsoun Malakoti-Fard, Agnė Mačiūnien, Akira Kawashima, Ana M.M. de M.G. de Sousa Machadov, Ana Sofia L. Moreira, Andrea Ponsiglione, Annelies Rappaport, Arnaldo Stanzione, Arturas Ciuvasovas, Baris Turkbey, Bart de Keyzer, Bodil G. Pedersen, Bram Eijlers, Christine Chen, Ciabattoni Riccardo, Deniz Alis, Ewout F.W. Courrech Staal, Fredrik Jäderling, Fredrik Langkilde, Giacomo Aringhieri, Giorgio Brembilla, Hannah Son, Hans Vanderlelij, Henricus P.J. Raat, Ingrida Pikūnienė and 56 more - The Lancet Oncology 2024 cited by 273

  4. Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Ross Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Dan George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raja Leibowitz, Christopher Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Amee Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki and 18 more - European Journal of Cancer 2023 cited by 157

  5. Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancer

    Authors: , , , , , , , , , , , , , , , , , - Annals of Oncology 2023 cited by 113

  6. Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer

    Authors: , , , , , , , , , , - European Journal of Nuclear Medicine and Molecular Imaging 2020 cited by 205

  7. Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study

    Authors: , , , , , , , , , , , , , , , , , , , , - European Urology 2016 cited by 419

  8. Carbon Monoxide Expedites Metabolic Exhaustion to Inhibit Tumor Growth

    Authors: , , , , , , , , , , , , , , - Cancer Research 2013 cited by 373

  9. Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Rosalind A. Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Daniel J. George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia S. Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raya Leibowitz‐Amit, Christopher J. Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Alicia K. Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver A. Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki and 18 more - European Urology 2022 cited by 118

  10. Urinary Incontinence and Erectile Dysfunction After Robotic Versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial

    Authors: , , , , , , , , , , , - European Urology 2015 cited by 491

  11. The 5-Hydroxymethylcytosine Landscape of Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul Lloyd, Tierney Phillips, Erin McCarthy, Michael C. Haffner, Amina Zoubeidi, Matti Annala, Robert E. Reiter, Matthew B. Rettig, Owen N. Witte, Lawrence Fong, Rohit Bose, Franklin W. Huang, Jianhua Luo, Anders Bjartell, Joshua M. Lang, Nupam P. Mahajan, Primo N. Lara, Christopher P. Evans, Phuoc T. Tran, Edwin M. Posadas, Chuan He, Xiaolong Cui, Jiaoti Huang, Wilbert Zwart, Luke A. Gilbert, Christopher A. Maher, Paul C. Boutros, Kim N., Alan Ashworth, Eric J. Small, Housheng Hansen He, Alexander W. Wyatt, David A. Quigley, Felix Y. Feng - Cancer Research 2022 cited by 67

  12. EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tobias Gross, Jeremy Grummet, Ann Henry, Alexandre Ingels, Jacques Irani, Michael Lardas, Matthew Liew, Daniel W. Lin, Lisa Moris, Muhammad Imran Omar, Karl H. Pang, Catherine Paterson, Raphaële Renard‐Penna, María J. Ribal, Monique J. Roobol, Morgan Rouprêt, Olivier Rouvière, Gemma Sancho, Jonathan Richenberg, Ivo G. Schoots, J.P. Michiel Sedelaar, Phillip D. Stricker, Derya Tilki, Susanne Vahr Lauridsen, Roderick C.N. van den Bergh, Thomas Van den Broeck, Theodorus van der Kwast, Henk G. van der Poel, Geert J.L.H. van Leenders, Murali Varma, Philippe D. Violette, Christopher J.D. Wallis, Thomas Wiegel, Karen Wilkinson, Fabio Zattoni, James Michael Olu N'Dow, Hendrik Van Poppel, Philip Cornford, Nicolas Mottet - European Urology 2019 cited by 239

  13. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philip W. Kantoff, Raja B. Khauli, Raya Leibowitz‐Amit, Chris Logothetis, Fernando Cotait Maluf, Robin Millman, Alicia K. Morgans, Michael J. Morris, Nicolas Mottet, Hind M’rabti, Declan G. Murphy, Vedang Murthy, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Chris Parker, Darren M.C. Poon, Colin C. Pritchard, Robert E. Reiter, Mack Roach, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Neal D. Shore, Eric J. Small, Matthew R. Smith, Howard R. Soule, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki, Christopher J. Sweeney, Matthew R. Sydes, Mary-Ellen Taplin, Bertrand Tombal, Levent Türkeri, Inge M. van Oort, A. Zapatero, Aurelius Omlin - European Urology 2020 cited by 395

  14. Real-World Outcomes in First-Line Treatment of Metastatic Castration-Resistant Prostate Cancer: The Prostate Cancer Registry

    Authors: , , , , , , , , , , , , , , , - Targeted Oncology 2020 cited by 88

  15. Population-based Organised Prostate Cancer Testing: Results from the First Invitation of 50-year-old Men

    Authors: , , , , , , , , , , , , - European Urology 2023 cited by 62

  16. Functional and Oncological Outcomes After Open Versus Robot-assisted Laparoscopic Radical Prostatectomy for Localised Prostate Cancer: 8-Year Follow-up

    Authors: , , , , , , , , , , , , - European Urology 2021 cited by 114

  17. European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Oliver Sartor, Stefano Fanti - European Urology 2023 cited by 44

  18. Multicomponent Moraxella catarrhalis outer membrane vesicles induce an inflammatory response and are internalized by human epithelial cells

    Authors: , , , , , , , , - Cellular Microbiology 2010 cited by 131

  19. Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Celesta Higano, Michael S. Hofman, Maha Hussain, Nick James, Robert J. Jones, Ravindran Kanesvaran, Raja B. Khauli, Laurence Klotz, Raya Leibowitz‐Amit, Chris Logothetis, Fernando Cotait Maluf, Robin Millman, Alicia K. Morgans, Michael J. Morris, Nicolas Mottet, Hind M’rabti, Declan G. Murphy, Vedang Murthy, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Chris Parker, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Rob E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Neal D. Shore, Iwona Skoneczna, Eric J. Small, Matthew R. Smith, Howard R. Soule, Daniel E. Spratt, Cora N. Sternberg, Hiroyoshi Suzuki, Christopher J. Sweeney, Matthew R. Sydes, Mary‐Ellen Taplin, Derya Tilki, Bertrand Tombal, Levent Türkeri, Hiroji Uemura, Hirotsugu Uemura, Inge M. van Oort, Kosj Yamoah, Dingwei Ye, A. Zapatero, Aurelius Omlin - European Urology 2022 cited by 128

  20. Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Heather H. Cheng, Kim N., Caroline S. Clarke, Noel W. Clarke, Johann S. de Bono, Maria De Santis, Ignacio Durán, Eleni Efstathiou, Onyeanunam Ngozi Ekeke, Tamer I H El Nahas, Louise Emmett, Stefano Fanti, Omolara Fatiregun, Felix Y. Feng, Peter C.C. Fong, Valérie Fonteyne, Nicola Fossati, Daniel J. George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Michael S. Hofman, Thomas A. Hope, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Anthony M. Joshua, R. Kanesvaran, Daniel Keizman, Raja B. Khauli, Gero Kramer, Stacy Loeb, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Mika Matikainen, Ray McDermott, Rana R. McKay, Niven Mehra, Axel S. Merseburger, Alicia K. Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Shingai B.A. Mutambirwa, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Chris Parker, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Raphaële Renard‐Penna, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Shahneen Sandhu, Oliver A. Sartor, Edward M. Schaeffer, Howard I. Scher and 21 more - European Urology 2024 cited by 115

  21. The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Per‐Uno Malmström, Martin Johansson, Björn Nodin, Max Backman, Cecilia Lindskog, Karin Jirström, Artur Mezheyeuski - EBioMedicine 2021 cited by 63

  22. An Artificial Intelligence–based Support Tool for Automation and Standardisation of Gleason Grading in Prostate Biopsies

    Authors: , , , , , , , - European Urology Focus 2020 cited by 55

  23. Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS”

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eva Hellmis, Andreas Schneider, Spiegelhalder, Manfred P. Wirth, Theodor Klotz, H. Suttmann, Michael Siebels, Gerd Rodemer, Robert H. Rudolph, Roger Zillmann, Marie L. De Bruin, Sarah Bos, R. van Moorselaar, T. De Reijke, Joost L. Boormans, Bart P. Wijsman, Harm H.E. van Melick, E. Boven, Richard P. Meijer, Antoine G. van der Heijden, H. Vergunst, E. te Slaa, Anna M. Leliveld, Marc Colombel, A. Ruffion, Christian Pfister, Morgan Rouprêt, Jacques Irani, Gabriel Stoica, Siska Van Bruwaene, Filip Ameye, H.C. Arentsen, Steven Joniau, Pastora Beardo - European Urology 2020 cited by 133

  24. Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , R. Valdagni, Antoinette S. Perry, Jonas Hugosson, J. Rubio‐Briones, Anders Bjartell, Lukas Hefermehl, Lee Lui Shiong, Mark Frydenberg, Yoshiyuki Kakehi, Byung Ha Chung, Theodorus van der Kwast, Henk Obbink, Wim van der Linden, Tim Hulsen, Cees de Jonge, Mike Kattan, Xinge Ji, Kenneth Muir, Artitaya Lophatananon, Michael Fahey, Ewout W. Steyerberg, Daan Nieboer, Liying Zhang, Ewout W. Steyerberg, Daan Nieboer, A. Santa Olalla, Kerri Beckmann, Brian T. Denton, Andrew Hayen, Paul C. Boutros, Wei Guo, Nicole Benfante, Janet E. Cowan, Dattatraya Patil, Emily Tolosa, Tae-Kyung Kim, Alexandre Mamedov, Vincent La Pointe, Trafford Crump, Jenna Kimberly-Duffell, Aida Santaolalla, Daan Nieboer, Jonathan Olivier, T. Rancati, Helén Ahlgren, Juanma Mascarós, Annica Löfgren, Kurt Lehmann, Catherine Han Lin, Hiromi Hirama, Kwang Suk Lee, Guido Jenster, Anssi Auvinen, Anders Bjartell, Masoom A. Haider, Kees van Bochove, Ballentine Carter, Sam Gledhill, Mark Buzza, Chris H. Bangma, Monique J. Roobol, Sophie Bruinsma, Jozien Helleman - European Urology 2018 cited by 93